SKO-TRZ Peptide is a synthetic research peptide identified by research catalogs as tirzepatide (TRZ), a dual GIP and GLP-1 receptor agonist. Tirzepatide is a 39-amino-acid peptide studied extensively for its effects on incretin receptor signaling, glucose metabolism, appetite regulation, energy b